Stereotaxis will feature its cutting-edge surgical robotics at the SCRN Annual Meeting in Lisbon on October 28-29, showcasing applications in cardiology. The conference will gather over forty leading physicians to share insights on technological advancements, including AI and novel robotic catheters. Stereotaxis aims to enhance minimally invasive interventions, emphasizing patient outcomes through innovative techniques.
Stereotaxis is poised to showcase its groundbreaking surgical robotics at the upcoming Society for Cardiac Robotic Navigation (SCRN) Annual Meeting in Lisbon from October 28-29. As a leader in minimally invasive endovascular interventions, Stereotaxis will spotlight their innovative robotic technologies through demos, presentations, and discussions, engaging over forty renowned physicians from North America, Europe, and Asia. The SCRN conference serves as a pivotal platform for healthcare professionals to exchange insights on the latest advancements in robotic technologies applied in cardiology. Key topics will encompass developments in artificial intelligence, the digitization of operating rooms, as well as novel robotic catheters and the MAGiC ablation catheter’s clinical applications. David Fischel, Stereotaxis’ CEO, expressed enthusiasm about participating in SCRN, emphasizing the conference’s relevance in highlighting robotics’ transformative potential in cardiology. Stereotaxis aims to enhance patient outcomes across various clinical settings, underpinning their commitment to innovation in surgical robotics. Stereotaxis has treated over 100,000 patients globally, striving to broaden minimally invasive therapeutic approaches through precision-driven technology. Their mission focuses on delivering cutting-edge robotic systems and information solutions for interventional labs, significantly improving surgical efficiency and patient safety.
The Society for Cardiac Robotic Navigation (SCRN) conference is dedicated to uniting professionals in the ever-evolving field of robotic-assisted cardiology. As advancements in technology continue to reshape the landscape, gatherings like SCRN provide crucial opportunities for sharing knowledge and experiences, ensuring healthcare professionals are equipped with the latest insights and innovations. Stereotaxis, a frontrunner in surgical robotics, emphasizes minimizing invasiveness and maximizing patient care. Their technologies and instruments have been instrumental for healthcare professionals in navigating complex endovascular procedures, affecting practices in hospitals worldwide while adopting robotic capabilities to enhance treatment efficacy.
In summary, Stereotaxis is set to play a significant role in the SCRN Annual Meeting, reflecting the increasing integration of robotics in cardiology. With key discussions focusing on innovative technologies and clinical practices, the event represents a vital convergence of knowledge for cardiovascular professionals. Stereotaxis remains committed to driving advancements in surgical robotics, ultimately improving patient outcomes in diverse clinical environments.
Original Source: tech.einnews.com
